A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

386

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

October 31, 2011

Study Completion Date

December 31, 2011

Conditions
Prostate Cancer
Interventions
DRUG

Degarelix 80 mg / Degarelix 80 mg

DRUG

Degarelix 160 mg / Degarelix 160 mg

DRUG

Leuprolide 7.5 mg / Degarelix 80 mg

DRUG

Leuprolide 7.5 mg / Degarelix 160 mg

Trial Locations (69)

Unknown

Urology Centers Of Alabama, Homewood

South Orange County Medical Research Center, Laguna Hills

Western Clinical Research, Torrance

Urology Associates Research, Englewood

South Florida Medical Research, Aventura

Investigational Site, Ocala

Regional Urology, Shreveport

Lawrenceville Urology, Lawrenceville

Investigational Site, Carmel

North Urology Research, Concord

Investigational Site, Greensboro

State College Urologic Association, State College

Urology San Antonio Research, San Antonio

Seattle Urology Research Center, Burien

Investigational Site, Kentville

The Female/Male Health Centres, Barrie

Brantford Urology Research, Brantford

Burlington Professional Centre, Burlington

The Urology Research Centre, Burlington

Investigational Site, Newmarket

The Female/Male Health Centres, Oakville

Urology South Shore Research, Greenfields

Can-Med Clinical Research Inc, Victoria

Urocentrum Brno, Brno

UROHELP - Bozetechova, Brno

Nemocnice Jindrichuv Hradec, a.s., Jindřichův Hradec

Fakultni Nemocnice Olomouc, Olomouc

Slezska nemocnice, Opava

Fakultni nemocnice v Motole, Prague5, Prague

Vseobecna fakultni nemocnice v Praze, Prague2, Prague

Klinikum Mannheim Universitätsklinikum GmbH, Mannheim

Klinikum der Universität Regensburg, Regensburg

Fövárosi Önkormányzat uzsoki utcai Kórház, Budapest

Dombóvári Szent Lukács Egészségügyi Kht., Dombóvár

Petz Aladár Megyei Oktató Kórház, Győr

Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház, Miskolc

Miskolci Semmelweis Ignác Egészségügyi Központ és Egyetemi Oktató Kórház Nonprofit Kft, Miskolc

Pécsi Tudományegyetem, Pécs

Investigational Site, Szeged

Investigational Site, Acapulco

Hospital Christus Muguerza del Parque, Chihuahua, Chih.

Investigational Sit, Durango

Hospital Aranda de la Parra , S.A. de C.V., Leon, GTO

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Mexico, DF Mexico, Mexico City

Investigational Site, Mexico City

Consultorio Medico, Zapopan, Jalisco

Investigational Site, Zapopan, Jalisco

Investigational Site, Ede

Investigational Site, Eindhoven

Atrium MC, Heerlen

Hospital Andres Grillasca, Ponce

Investigational Site, Arad

Fundeni Uronephrology and Renal Transplant Clinical Institute, Bucharest

Investigational Site, Bucharest

"Sfantul Ioan Emergency Clinical Hospital", Bucharest

PROVITA 2000 Medical Center, Constanța

Investigational Site, Iași

Sibiu Emergency Clinical County Hospital, Sibiu

City Clinical Hospital #1 n.a. N.I.Pirogov, Moscow

City Clinical Hospital #60, Moscow

Moscow State University of Medicine and Dentistry, Moscow

City Pokrovskaya Hospital, Saint Petersburg

Investigational Site, Saint Petersburg

St.Petersburg State Medical Academy n. a. I.I.Mechnikov, Saint Petersburg

Dnipropetrovsk State Medical Academy, Dnipropetrovsk

Regional Clinical Center of Urology and Nephrology n.a. V.I.Shapoval, Kharkiv

Kyiv City Clinical Hospital #3, Kyiv

Odesa State Medical University, Odesa

Clatterbridge Centre For Oncology, Bebington, Wirral

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY